欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Human HLA class I histocompatibility antigen, B-46 alpha chain (HLA-B), partial CSB-YP329998HU
CSB-EP329998HU
CSB-BP329998HU
CSB-MP329998HU
CSB-EP329998HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human HLA class I histocompatibility antigen, B-54 alpha chain (HLA-B), partial CSB-YP329999HU
CSB-EP329999HU
CSB-BP329999HU
CSB-MP329999HU
CSB-EP329999HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human HLA class I histocompatibility antigen, Cw-4 alpha chain (HLA-C), partial CSB-YP330000HU
CSB-EP330000HU
CSB-BP330000HU
CSB-MP330000HU
CSB-EP330000HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saguinus oedipus Saoe class I histocompatibility antigen, C alpha chain, partial CSB-YP330001SWB
CSB-EP330001SWB
CSB-BP330001SWB
CSB-MP330001SWB
CSB-EP330001SWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hordeum vulgare Glucose-1-phosphate adenylyltransferase large subunit 1, chloroplastic/amyloplastic CSB-YP330002HWQ
CSB-EP330002HWQ
CSB-BP330002HWQ
CSB-MP330002HWQ
CSB-EP330002HWQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 1,4-alpha-glucan branching enzyme GlgB (glgB), partial CSB-YP330003BAI
CSB-EP330003BAI
CSB-BP330003BAI
CSB-MP330003BAI
CSB-EP330003BAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays Metallothionein-like protein 1 CSB-YP330004ZAX
CSB-EP330004ZAX
CSB-BP330004ZAX
CSB-MP330004ZAX
CSB-EP330004ZAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulatus Chitin synthase 3 (CHS3) CSB-YP330005AZC
CSB-EP330005AZC
CSB-BP330005AZC
CSB-MP330005AZC
CSB-EP330005AZC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Chitin synthase A (chsA), partial CSB-YP330006EKF
CSB-EP330006EKF
CSB-BP330006EKF
CSB-MP330006EKF
CSB-EP330006EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeococcomyces exophialae Chitin synthase 2 (CHS2) CSB-YP330007PGP
CSB-EP330007PGP
CSB-BP330007PGP
CSB-MP330007PGP
CSB-EP330007PGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ustilago maydis Chitin synthase 2 (CHS2), partial CSB-YP330008UBS
CSB-EP330008UBS
CSB-BP330008UBS
CSB-MP330008UBS
CSB-EP330008UBS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae DNA cross-link repair protein PSO2/SNM1 (PSO2), partial CSB-YP330009SVG
CSB-EP330009SVG
CSB-BP330009SVG
CSB-MP330009SVG
CSB-EP330009SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Globin-like protein (glb-1) CSB-YP330010CXY
CSB-EP330010CXY
CSB-BP330010CXY
CSB-MP330010CXY
CSB-EP330010CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized RING finger protein ZK637.14 (ZK637.14) CSB-YP330011CXY
CSB-EP330011CXY
CSB-BP330011CXY
CSB-MP330011CXY
CSB-EP330011CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative transporter ZK637.1 (ZK637.1), partial CSB-YP330012CXY
CSB-EP330012CXY
CSB-BP330012CXY
CSB-MP330012CXY
CSB-EP330012CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized protein ZK643.7 (ZK643.7) CSB-YP330014CXY
CSB-EP330014CXY
CSB-BP330014CXY
CSB-MP330014CXY
CSB-EP330014CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis DNA replication licensing factor mcm4-B (mcm4-b), partial CSB-YP330015XBE
CSB-EP330015XBE
CSB-BP330015XBE
CSB-MP330015XBE
CSB-EP330015XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human HLA class I histocompatibility antigen, B-35 alpha chain (HLA-B), partial CSB-YP330016HU
CSB-EP330016HU
CSB-BP330016HU
CSB-MP330016HU
CSB-EP330016HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helianthus annuus 17.6 kDa class I heat shock protein (HSP17.6) CSB-YP330017HUO
CSB-EP330017HUO
CSB-BP330017HUO
CSB-MP330017HUO
CSB-EP330017HUO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Momordica charantia Trypsin inhibitor A CSB-YP330018MHQ
CSB-EP330018MHQ
CSB-BP330018MHQ
CSB-MP330018MHQ
CSB-EP330018MHQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×